ARRHYTHMIA Edited by Yingmin Chen
Definition of Arrhythmia: The  Origin, Rate, Rhythm, Conduct velocity and sequence  of heart activation are  abnormally .
Anatomy of the conducting system
Pathogenesis and Inducement  of Arrhythmia  Some physical condition Pathological heart disease Other system disease  Electrolyte disturbance and acid-base imbalance Physical and chemical factors or toxicosis
Mechanism of Arrhythmia Abnormal heart pulse formation Sinus pulse Ectopic pulse Triggered activity Abnormal heart pulse conduction Reentry Conduct block
Classification of Arrhythmia Abnormal heart pulse formation Sinus arrhythmia Atrial arrhythmia Atrioventricular junctional arrhythmia Ventricular arrhythmia   Abnormal heart pulse conduction Sinus-atrial block Intra-atrial block Atrio-ventricular block Intra-ventricular block Abnormal heart pulse formation and conduction
Diagnosis of Arrhythmia Medical history Physical examination Laboratory test
Therapy Principal Pathogenesis therapy Stop the arrhythmia immediately  if the hemodynamic was unstable Individual therapy
Anti-arrhythmia Agents Anti-tachycardia agents Anti-bradycardia agents
Anti-tachycardia agents Modified Vaugham Williams classification I class: Natrium channel blocker II class:  ß-receptor blocker III class: Potassium channel blocker IV class: Calcium channel blocker Others: Adenosine, Digital
Anti-bradycardia agents ß-adrenic receptor activator M- cholinergic receptor blocker Non-specific activator
Clinical usage Anti-tachycardia agents:   Ia class: Less use in clinic Guinidine Procainamide Disopyramide:  Side effect: like  M- cholinergic receptor blocker
Anti-tachycardia agents:   Ib class: Perfect to ventricular tachyarrhythmia 1. Lidocaine   2. Mexiletine
Anti-tachycardia agents:   Ic class: Can be used in ventricular and/or supra-ventricular tachycardia and extrasystole.  1. Moricizine   2. Propafenone
Anti-tachycardia agents: II class: ß-receptor blocker Propranolol:  Non-selective Metoprolol:  Selective  ß 1 -receptor blocker, Perfect to hypertension and coronary artery disease patients associated with tachyarrhythmia.
Anti-tachycardia agents: III class: Potassium channel blocker, extend-spectrum anti-arrhythmia agent. Amioarone: Perfect to coronary artery disease and heart failure patients Sotalol: Has ß-blocker effect Bretylium
Anti-tachycardia agents: IV class: be used in supraventricular tachycardia Verapamil Diltiazem Others: Adenosine: be used in supraventricular tachycardia
Anti-bradycardia agents Isoprenaline Epinephrine Atropine Aminophylline
Proarrhythmia effect of antiarrhythmia agents Ia, Ic class: Prolong QT interval, will cause VT or VF in coronary artery disease and heart failure patients III class: Like Ia, Ic class agents II, IV class: Bradycardia
Non-drug therapy Cardioversion: For tachycardia especially hemodynamic unstable patient Radiofrequency catheter ablation (RFCA): For those tachycardia patients (SVT, VT, AF, AFL) Artificial cardiac pacing: For bradycardia, heart failure and malignant ventricular arrhythmia patients.
Sinus Arrhythmia
Sinus tachycardia   Sinus rate > 100 beats/min (100-180) Causes: Some physical condition: exercise, anxiety, exciting, alcohol, coffee Some disease: fever, hyperthyroidism, anemia, myocarditis  Some drugs: Atropine, Isoprenaline  Needn’t therapy
Sinus   Bradycardia Sinus rate < 60 beats/min  Normal variant in many normal and older people Causes:   Trained athletes, during sleep, drugs ( ß-blocker ) , Hypothyriodism, CAD or SSS Symptoms: Most patients have no symptoms. Severe bradycardia may cause dizziness, fatigue, palpitation, even syncope.  Needn’t specific therapy , If the patient has severe symptoms, planted an pacemaker may be needed.
Sinus Arrest or Sinus Standstill Sinus arrest or standstill is recognized by a pause in the sinus rhythm.  Causes:   myocardial ischemia, hypoxia, hyperkalemia, higher intracranial pressure, sinus node degeneration and some drugs (digitalis,  ß-blocks) . Symptoms:  dizziness, amaurosis, syncope Therapy  is same to SSS
Sinoatrial exit block (SAB) SAB: Sinus pulse was blocked so it couldn’t active the atrium. Causes: CAD, Myopathy, Myocarditis, digitalis toxicity, et al. Symptoms: dizziness, fatigue, syncope Therapy is same to SSS
Sinoatrial exit block (SAB) Divided into three types: Type I, II, III Only type II SAB can be recognized by EKG.
Sick Sinus Syndrome (SSS) SSS: The function of sinus node was degenerated. SSS encompasses both disordered SA node automaticity and SA conduction. Causes: CAD, SAN degeneration, myopathy, connective tissue disease, metabolic disease, tumor, trauma and congenital disease. With marked sinus bradycardia, sinus arrest, sinus exit block or junctional escape rhythms Bradycardia-tachycardia syndrome
Sick Sinus Syndrome (SSS) EKG Recognition: Sinus bradycardia,  ≤40 bpm ;  Sinus arrest > 3s Type II SAB Nonsinus tachyarrhythmia ( SVT, AF or Af). SNRT > 1530ms, SNRTc > 525ms Instinct  heart rate < 80bmp
 
Sick Sinus Syndrome (SSS) Therapy: Treat the etiology Treat with drugs: anti-bradycardia agents, the effect of drug therapy is not good. Artificial cardiac pacing.
Atrial arrhythmia
Premature contractions The term “premature contractions” are used to describe non sinus beats.  Common arrhythmia The morbidity rate is 3-5%
Atrial premature contractions (APCs) APCs arising from somewhere in either the left or the right atrium. Causes:  rheumatic heart disease, CAD, hypertension, hyperthyroidism, hypokalemia Symptoms:  many patients have no symptom, some have palpitation, chest incomfortable. Therapy:  Needn’t therapy in the patients without heart disease. Can be treated with  ß-blocker, propafenone, moricizine or verapamil.
Atrial tachycardia Classify  by automatic atrial tachycardia (AAT); intra-atrial reentrant atrial tachycardia (IART); chaotic atrial tachycardia (CAT). Etiology:  atrial enlargement, MI; chronic obstructive pulmonary disease; drinking; metabolic disturbance; digitalis toxicity; electrolytic disturbance.
Atrial tachycardia May occur transient; intermittent; or persistent.  Symptoms: palpitation; chest uncomfortable, tachycardia may induce myopathy. Auscultation: the first heart sound is variable
Intra-atrial reentry tachycardia (IART) ECG characters: Atrial rate is around 130-150bpm; P’ wave is different from sinus P wave; P’-R interval  ≥ 0.12” Often appear type I or type II, 2:1 AV block; EP study: atrial program pacing can induce and terminate tachycardia
Automatic atrial tachycardia (AAT) ECG characters: Atrial rate is around 100-200bpm; Warmup phenomena P’ wave is different from sinus P wave; P’-R interval ≥ 0.12” Often appear type I or type II, 2:1 AV block; EP study: Atrial program pacing can’t induce or terminate the tachycardia
 
Chaotic atrial tachycardia (CAT) Also termed “Multifocal atrial tachycardia”. Always occurs in COPD or CHF,  Have a high in-hospital mortality ( 25-56%). Death is caused by the severity of the underlying disease.   ECG characters: Atrial rate is around 100-130bpm; The morphologies P’ wave are more than 3 types. P’-P’, P’-R and R-R interval are different. Will progress to af in half the cases EP study: Atrial program pacing can’t induce or terminate the tachycardia
 
Therapy IRAT:   Esophageal Pulsation Modulation, RFCA, Ic and IV class anti-tachycardia agents AAT: Digoxin, IV, II, Ia and III class anti-tachycardia agents; RFCA CAT: treat the underlying disease, verapamil or amiodarone. Associated with SSS: Implant pace-maker.
Atrial flutter Etiology: It can occur in patients with normal atrial or with abnormal atrial. It is seen in rheumatic heart disease (mitral or tricuspid valve disease), CAD, hypertension, hyperthyroidism, congenital heart disease, COPD.  Related to enlargement of the atria Most AF have a reentry loop in right atrial
 
Atrial flutter Symptoms:  depend on underlying disease, ventricular rate, the patient is at rest or is exerting  With rapid ventricular rate: palpitation, dizziness, shortness of breath, weakness, faintness, syncope, may develop angina and CHF.
Atrial flutter Therapy: Treat the underlying disease To restore sinus rhythm: Cardioversion,   Esophageal Pulsation Modulation, RFCA, Drug (III, Ia, Ic class). Control the ventricular rate: digitalis. CCB,  ß-block Anticoagulation
Atrial fibrillation Subdivided into three types: paroxysmal, persistent, permanent.   Etiology: Morbidity rate increase in older patients Etiology just like atrial flutter Idiopathic Mechanism:   Multiple wavelet re-entry; Rapid firing focus in pulmonary vein, vena cava or coronary sinus.
 
Atrial fibrillation Manifestation: Affected by underlying diseases, ventricular rate and heart function.  May develop embolism in left atrial. Have high incidence of stroke. The heart rate, S1 and rhythm is irregularly irregular If the heart rhythm is regular, should consider about (1) restore sinus rhythm; (2) AF with constant the ratio of AV conduction; (3) junctional or ventricular tachycardia; (4) slower ventricular rate may have complete AV block.
Atrial fibrillation Therapy: Treat the underlying disease Restore sinus rhythm: Drug, Cardioversion, RFCA, Maze surgery Rate control:   digitalis. CCB,  ß-block Antithrombotic therapy: Aspirine, Warfarin
Atrioventricular Junctional arrhythmia
Atrioventricular junctional premature contractions Etiology and manifestation is like APCs Therapy the underlying disease Needn’t anti-arrhythmia therapy.
Nonparoxysmal AV junctional tachycardia Mechanism:  relate to hyper-automaticity  or trigger activity of AV junctional tissue Etiology:  digitalis toxicity; inferior MI; myocarditis; acute rheumatic fever and postoperation of valve disease ECG:  the heart rate ranges 70-150 bpm or more, regular, normal QRS complex, may occur AV dissociation and wenckebach AV block
Nonparoxysmal AV junctional tachycardia Therapy:   Treat underlying disease; stopping digoxin, administer potassium, lidocaine, phenytoin or propranolol. Not for DC shock It can disappear spontaneously. If had good tolerance, not require therapy.
Paroxysmal tachycardia Most PSVT (paroxysmal supraventricular tachycardia) is due to reentrant mechanism.  The incidence of PSVT is higher in AVNRT (atrioventricular node reentry tachycardia) and AVRT (atioventricular reentry tachycardia), the most common is AVNRT (90%) Occur in any age individuals, usually no structure heart disease.
Paroxysmal tachycardia Manifestation:   Occur and terminal abruptly. Palpitation, dizziness, syncope, angina, heart failure and shock. The sever degree of the symptom is related to ventricular rate, persistent duration and underlying disease
Paroxysmal tachycardia ECG characteristic of AVNRT Heart rate is 150-250 bpm, regular  QRS complex is often normal,  wide QRS complex is with aberrant conduction Negative P wave in II III aVF, buried into or following by the QRS complex.  AVN jump phenomena
Paroxysmal tachycardia ECG characteristic of AVRT Heart rate is 150-250 bpm, regular  In orthodromic AVRT, the QRS complex is often normal,  wide QRS complex is with antidromic AVRT Retrograde P’ wave, R-P’>110ms.
Paroxysmal tachycardia Therapy:   AVNRT & orthodromic AVRT Increase vagal tone: carotid sinus massage,  Valsalva maneuver.if no successful,  Drug: verapamil, adrenosine, propafenone DC shock Antidromic AVRT: Should not use verapamil, digitalis, and stimulate the vagal nerve. Drug: propafenone, sotalol, amiodarone  RFCA
Pre-excitation syndrome (W-P-W syndrome) There are several type of accessory pathway Kent: adjacent atrial and ventricular  James: adjacent atrial and his bundle Mahaim: adjacent lower part of the AVN and ventricular Usually no structure heart disease, occur in any age individual
WPW syndrome Manifestation: Palpitation, syncope, dizziness  Arrhythmia: 80% tachycardia is AVRT, 15-30% is AFi, 5% is AF,  May induce ventricular fibrillation
WPW syndrome Therapy: Pharmacologic therapy: orthodrome AVRT or associated AF, AFi, may use Ic and III class agents.  Antidromic AVRT can’t use digoxin and verapamil. DC shock: WPW with SVT, AF or Afi produce agina, syncope and hypotension RFCA
Ventricular arrhythmia
Ventricular Premature Contractions (VPCs) Etiology: Occur in normal person Myocarditis, CAD, valve heart disease, hyperthyroidism, Drug toxicity (digoxin, quinidine and anti-anxiety drug) electrolyte disturbance, anxiety, drinking,   coffee
VPCs   Manifestation:  palpitation dizziness syncope  loss of the second heart sound
PVCs Therapy:  treat underlying disease, antiarrhythmia No structure heart disease:   Asymptom: no therapy  Symptom caused by PVCs: antianxiety agents,  ß -blocker and mexiletine to relief the symptom. With structure heart disease (CAD, HBP): Treat the underlying diseas ß -blocker, amiodarone Class I especially class Ic agents should be avoided because of proarrhytmia and lack of benefit of prophylaxis
Ventricular tachycardia Etiology: often in organic heart disease  CAD, MI, DCM, HCM, HF,  long QT syndrome  Brugada syndrome Sustained VT (>30s), Nonsustained VT Monomorphic VT, Polymorphic VT
Ventricular tachycardia Torsades de points (Tdp):  A special type of polymorphic VT,  Etiology:   congenital (Long QT),  electrolyte disturbance,  antiarrhythmia drug proarrhythmia (IA or IC),  antianxiety drug,  brain disease,  bradycardia
Ventricular tachycardia Accelerated idioventricular rhythm: Related to increase automatic tone Etiology : Often occur in organic heart disease, especially AMI reperfusion periods, heart operation, myocarditis, digitalis toxicity
VT Manifestation:  Nonsustained VT with no symptom  Sustained VT : with symptom and unstable hemodynamic, patient may feel palpitation, short of breathness, presyncope, syncope, angina, hypotension and shock.
VT ECG characteristics:   Monomorphic VT: 100-250 bpm, occur and terminate abruptly,regular  Accelerated idioventricular rhythm: a runs of 3-10  ventricular beats, rate of 60-110 bpm, tachycardia is a capable of warm up and close down, often seen AV dissociation, fusion or capture beats  Tdp: rotation of the QRS axis around the baseline, the rate from 160-280 bpm, QT interval prolonged > 0.5s, marked  U wave
Treatment of VT Treat underlying disease Cardioversion: Hemodynamic unstable VT (hypotension, shock, angina, CHF) or hemodynamic stable but drug was no effect Pharmacological therapy:  ß-blockers,  lidocain or amiodarone RFCA, ICD or surgical therapy
Therapy of Special type VT Accelerated idioventricular rhythm: usually no symptom, needn’t therapy.  Atropine increased sinus rhythm Tdp: Treat underlying disease,  Magnesium iv, atropine or isoprenaline,  ß -block or pacemaker for long QT patient temporary pacemaker
Ventricular flutter and fibrillation Often occur in severe organic heart disease: AMI, ischemia heart disease Proarrhythmia (especially produce long QT and Tdp), electrolyte disturbance Anaesthesia, lightning strike, electric shock, heart operation It’s a fatal arrhythmia
Ventricular flutter and fibrillation Manifestation: Unconsciousness, twitch, no blood pressure and pulse, going to die Therapy: Cardio-Pulmonary Resuscitate   (CPR) ICD
Cardiac conduction block Block position: Sinoatrial; intra-atrial; atrioventricular; intra-ventricular Block degree Type I: prolong the conductive time Type II: partial block Type III: complete block
Atrioventricular Block AV block is a delay or failure in transmission of the cardiac impulse from atrium to ventricle. Etiology: Atherosclerotic heart disease; myocarditis; rheumatic fever; cardiomyopathy; drug toxicity; electrolyte disturbance, collagen disease, lev’s disease.
AV Block AV block is divided into three categories: First-degree AV block Second-degree AV block: further subdivided into type I and type II Third-degree AV block: complete block
AV Block Manifestations: First-degree AV block: almost no symptoms; Second degree AV block: palpitation, fatigue Third degree AV block: Dizziness, agina, heart failure, lightheadedness, and syncope may cause by slow heart rate, Adams-Stokes Syndrome may occurs in sever case. First heart sound varies in intensity, will appear booming first sound
AV Block Treatment: I or II degree AV block needn’t antibradycardia agent therapy II degree II type and III degree AV block need antibradycardia agent therapy Implant Pace Maker
Intraventricular Block Intraventricular conduction system:   Right bundle branch Left bundle branch Left anterior fascicular Left posterior fascicular
Intraventricular Block Etiology: Myocarditis, valve disease, cardiomyopathy, CAD, hypertension, pulmonary heart disease, drug toxicity,  Lenegre disease, Lev’s disease et al. Manifestation: Single fascicular or bifascicular block is asymptom; tri-fascicular block may have dizziness; palpitation, syncope and Adams-stokes syndrome
Intraventricular Block Therapy: Treat underlying disease If the patient is asymptom; no treat, bifascicular block and incomplete trifascicular block may progress to complete block, may need implant pace maker if the patient with syncope

ecg

  • 1.
  • 2.
    Definition of Arrhythmia:The Origin, Rate, Rhythm, Conduct velocity and sequence of heart activation are abnormally .
  • 3.
    Anatomy of theconducting system
  • 4.
    Pathogenesis and Inducement of Arrhythmia Some physical condition Pathological heart disease Other system disease Electrolyte disturbance and acid-base imbalance Physical and chemical factors or toxicosis
  • 5.
    Mechanism of ArrhythmiaAbnormal heart pulse formation Sinus pulse Ectopic pulse Triggered activity Abnormal heart pulse conduction Reentry Conduct block
  • 6.
    Classification of ArrhythmiaAbnormal heart pulse formation Sinus arrhythmia Atrial arrhythmia Atrioventricular junctional arrhythmia Ventricular arrhythmia Abnormal heart pulse conduction Sinus-atrial block Intra-atrial block Atrio-ventricular block Intra-ventricular block Abnormal heart pulse formation and conduction
  • 7.
    Diagnosis of ArrhythmiaMedical history Physical examination Laboratory test
  • 8.
    Therapy Principal Pathogenesistherapy Stop the arrhythmia immediately if the hemodynamic was unstable Individual therapy
  • 9.
    Anti-arrhythmia Agents Anti-tachycardiaagents Anti-bradycardia agents
  • 10.
    Anti-tachycardia agents ModifiedVaugham Williams classification I class: Natrium channel blocker II class: ß-receptor blocker III class: Potassium channel blocker IV class: Calcium channel blocker Others: Adenosine, Digital
  • 11.
    Anti-bradycardia agents ß-adrenicreceptor activator M- cholinergic receptor blocker Non-specific activator
  • 12.
    Clinical usage Anti-tachycardiaagents: Ia class: Less use in clinic Guinidine Procainamide Disopyramide: Side effect: like M- cholinergic receptor blocker
  • 13.
    Anti-tachycardia agents: Ib class: Perfect to ventricular tachyarrhythmia 1. Lidocaine 2. Mexiletine
  • 14.
    Anti-tachycardia agents: Ic class: Can be used in ventricular and/or supra-ventricular tachycardia and extrasystole. 1. Moricizine 2. Propafenone
  • 15.
    Anti-tachycardia agents: IIclass: ß-receptor blocker Propranolol: Non-selective Metoprolol: Selective ß 1 -receptor blocker, Perfect to hypertension and coronary artery disease patients associated with tachyarrhythmia.
  • 16.
    Anti-tachycardia agents: IIIclass: Potassium channel blocker, extend-spectrum anti-arrhythmia agent. Amioarone: Perfect to coronary artery disease and heart failure patients Sotalol: Has ß-blocker effect Bretylium
  • 17.
    Anti-tachycardia agents: IVclass: be used in supraventricular tachycardia Verapamil Diltiazem Others: Adenosine: be used in supraventricular tachycardia
  • 18.
    Anti-bradycardia agents IsoprenalineEpinephrine Atropine Aminophylline
  • 19.
    Proarrhythmia effect ofantiarrhythmia agents Ia, Ic class: Prolong QT interval, will cause VT or VF in coronary artery disease and heart failure patients III class: Like Ia, Ic class agents II, IV class: Bradycardia
  • 20.
    Non-drug therapy Cardioversion:For tachycardia especially hemodynamic unstable patient Radiofrequency catheter ablation (RFCA): For those tachycardia patients (SVT, VT, AF, AFL) Artificial cardiac pacing: For bradycardia, heart failure and malignant ventricular arrhythmia patients.
  • 21.
  • 22.
    Sinus tachycardia Sinus rate > 100 beats/min (100-180) Causes: Some physical condition: exercise, anxiety, exciting, alcohol, coffee Some disease: fever, hyperthyroidism, anemia, myocarditis Some drugs: Atropine, Isoprenaline Needn’t therapy
  • 23.
    Sinus Bradycardia Sinus rate < 60 beats/min Normal variant in many normal and older people Causes: Trained athletes, during sleep, drugs ( ß-blocker ) , Hypothyriodism, CAD or SSS Symptoms: Most patients have no symptoms. Severe bradycardia may cause dizziness, fatigue, palpitation, even syncope. Needn’t specific therapy , If the patient has severe symptoms, planted an pacemaker may be needed.
  • 24.
    Sinus Arrest orSinus Standstill Sinus arrest or standstill is recognized by a pause in the sinus rhythm. Causes: myocardial ischemia, hypoxia, hyperkalemia, higher intracranial pressure, sinus node degeneration and some drugs (digitalis, ß-blocks) . Symptoms: dizziness, amaurosis, syncope Therapy is same to SSS
  • 25.
    Sinoatrial exit block(SAB) SAB: Sinus pulse was blocked so it couldn’t active the atrium. Causes: CAD, Myopathy, Myocarditis, digitalis toxicity, et al. Symptoms: dizziness, fatigue, syncope Therapy is same to SSS
  • 26.
    Sinoatrial exit block(SAB) Divided into three types: Type I, II, III Only type II SAB can be recognized by EKG.
  • 27.
    Sick Sinus Syndrome(SSS) SSS: The function of sinus node was degenerated. SSS encompasses both disordered SA node automaticity and SA conduction. Causes: CAD, SAN degeneration, myopathy, connective tissue disease, metabolic disease, tumor, trauma and congenital disease. With marked sinus bradycardia, sinus arrest, sinus exit block or junctional escape rhythms Bradycardia-tachycardia syndrome
  • 28.
    Sick Sinus Syndrome(SSS) EKG Recognition: Sinus bradycardia, ≤40 bpm ; Sinus arrest > 3s Type II SAB Nonsinus tachyarrhythmia ( SVT, AF or Af). SNRT > 1530ms, SNRTc > 525ms Instinct heart rate < 80bmp
  • 29.
  • 30.
    Sick Sinus Syndrome(SSS) Therapy: Treat the etiology Treat with drugs: anti-bradycardia agents, the effect of drug therapy is not good. Artificial cardiac pacing.
  • 31.
  • 32.
    Premature contractions Theterm “premature contractions” are used to describe non sinus beats. Common arrhythmia The morbidity rate is 3-5%
  • 33.
    Atrial premature contractions(APCs) APCs arising from somewhere in either the left or the right atrium. Causes: rheumatic heart disease, CAD, hypertension, hyperthyroidism, hypokalemia Symptoms: many patients have no symptom, some have palpitation, chest incomfortable. Therapy: Needn’t therapy in the patients without heart disease. Can be treated with ß-blocker, propafenone, moricizine or verapamil.
  • 34.
    Atrial tachycardia Classify by automatic atrial tachycardia (AAT); intra-atrial reentrant atrial tachycardia (IART); chaotic atrial tachycardia (CAT). Etiology: atrial enlargement, MI; chronic obstructive pulmonary disease; drinking; metabolic disturbance; digitalis toxicity; electrolytic disturbance.
  • 35.
    Atrial tachycardia Mayoccur transient; intermittent; or persistent. Symptoms: palpitation; chest uncomfortable, tachycardia may induce myopathy. Auscultation: the first heart sound is variable
  • 36.
    Intra-atrial reentry tachycardia(IART) ECG characters: Atrial rate is around 130-150bpm; P’ wave is different from sinus P wave; P’-R interval ≥ 0.12” Often appear type I or type II, 2:1 AV block; EP study: atrial program pacing can induce and terminate tachycardia
  • 37.
    Automatic atrial tachycardia(AAT) ECG characters: Atrial rate is around 100-200bpm; Warmup phenomena P’ wave is different from sinus P wave; P’-R interval ≥ 0.12” Often appear type I or type II, 2:1 AV block; EP study: Atrial program pacing can’t induce or terminate the tachycardia
  • 38.
  • 39.
    Chaotic atrial tachycardia(CAT) Also termed “Multifocal atrial tachycardia”. Always occurs in COPD or CHF, Have a high in-hospital mortality ( 25-56%). Death is caused by the severity of the underlying disease. ECG characters: Atrial rate is around 100-130bpm; The morphologies P’ wave are more than 3 types. P’-P’, P’-R and R-R interval are different. Will progress to af in half the cases EP study: Atrial program pacing can’t induce or terminate the tachycardia
  • 40.
  • 41.
    Therapy IRAT: Esophageal Pulsation Modulation, RFCA, Ic and IV class anti-tachycardia agents AAT: Digoxin, IV, II, Ia and III class anti-tachycardia agents; RFCA CAT: treat the underlying disease, verapamil or amiodarone. Associated with SSS: Implant pace-maker.
  • 42.
    Atrial flutter Etiology:It can occur in patients with normal atrial or with abnormal atrial. It is seen in rheumatic heart disease (mitral or tricuspid valve disease), CAD, hypertension, hyperthyroidism, congenital heart disease, COPD. Related to enlargement of the atria Most AF have a reentry loop in right atrial
  • 43.
  • 44.
    Atrial flutter Symptoms: depend on underlying disease, ventricular rate, the patient is at rest or is exerting With rapid ventricular rate: palpitation, dizziness, shortness of breath, weakness, faintness, syncope, may develop angina and CHF.
  • 45.
    Atrial flutter Therapy:Treat the underlying disease To restore sinus rhythm: Cardioversion, Esophageal Pulsation Modulation, RFCA, Drug (III, Ia, Ic class). Control the ventricular rate: digitalis. CCB, ß-block Anticoagulation
  • 46.
    Atrial fibrillation Subdividedinto three types: paroxysmal, persistent, permanent. Etiology: Morbidity rate increase in older patients Etiology just like atrial flutter Idiopathic Mechanism: Multiple wavelet re-entry; Rapid firing focus in pulmonary vein, vena cava or coronary sinus.
  • 47.
  • 48.
    Atrial fibrillation Manifestation:Affected by underlying diseases, ventricular rate and heart function. May develop embolism in left atrial. Have high incidence of stroke. The heart rate, S1 and rhythm is irregularly irregular If the heart rhythm is regular, should consider about (1) restore sinus rhythm; (2) AF with constant the ratio of AV conduction; (3) junctional or ventricular tachycardia; (4) slower ventricular rate may have complete AV block.
  • 49.
    Atrial fibrillation Therapy:Treat the underlying disease Restore sinus rhythm: Drug, Cardioversion, RFCA, Maze surgery Rate control: digitalis. CCB, ß-block Antithrombotic therapy: Aspirine, Warfarin
  • 50.
  • 51.
    Atrioventricular junctional prematurecontractions Etiology and manifestation is like APCs Therapy the underlying disease Needn’t anti-arrhythmia therapy.
  • 52.
    Nonparoxysmal AV junctionaltachycardia Mechanism: relate to hyper-automaticity or trigger activity of AV junctional tissue Etiology: digitalis toxicity; inferior MI; myocarditis; acute rheumatic fever and postoperation of valve disease ECG: the heart rate ranges 70-150 bpm or more, regular, normal QRS complex, may occur AV dissociation and wenckebach AV block
  • 53.
    Nonparoxysmal AV junctionaltachycardia Therapy: Treat underlying disease; stopping digoxin, administer potassium, lidocaine, phenytoin or propranolol. Not for DC shock It can disappear spontaneously. If had good tolerance, not require therapy.
  • 54.
    Paroxysmal tachycardia MostPSVT (paroxysmal supraventricular tachycardia) is due to reentrant mechanism. The incidence of PSVT is higher in AVNRT (atrioventricular node reentry tachycardia) and AVRT (atioventricular reentry tachycardia), the most common is AVNRT (90%) Occur in any age individuals, usually no structure heart disease.
  • 55.
    Paroxysmal tachycardia Manifestation: Occur and terminal abruptly. Palpitation, dizziness, syncope, angina, heart failure and shock. The sever degree of the symptom is related to ventricular rate, persistent duration and underlying disease
  • 56.
    Paroxysmal tachycardia ECGcharacteristic of AVNRT Heart rate is 150-250 bpm, regular QRS complex is often normal, wide QRS complex is with aberrant conduction Negative P wave in II III aVF, buried into or following by the QRS complex. AVN jump phenomena
  • 57.
    Paroxysmal tachycardia ECGcharacteristic of AVRT Heart rate is 150-250 bpm, regular In orthodromic AVRT, the QRS complex is often normal, wide QRS complex is with antidromic AVRT Retrograde P’ wave, R-P’>110ms.
  • 58.
    Paroxysmal tachycardia Therapy: AVNRT & orthodromic AVRT Increase vagal tone: carotid sinus massage, Valsalva maneuver.if no successful, Drug: verapamil, adrenosine, propafenone DC shock Antidromic AVRT: Should not use verapamil, digitalis, and stimulate the vagal nerve. Drug: propafenone, sotalol, amiodarone RFCA
  • 59.
    Pre-excitation syndrome (W-P-Wsyndrome) There are several type of accessory pathway Kent: adjacent atrial and ventricular James: adjacent atrial and his bundle Mahaim: adjacent lower part of the AVN and ventricular Usually no structure heart disease, occur in any age individual
  • 60.
    WPW syndrome Manifestation:Palpitation, syncope, dizziness Arrhythmia: 80% tachycardia is AVRT, 15-30% is AFi, 5% is AF, May induce ventricular fibrillation
  • 61.
    WPW syndrome Therapy:Pharmacologic therapy: orthodrome AVRT or associated AF, AFi, may use Ic and III class agents. Antidromic AVRT can’t use digoxin and verapamil. DC shock: WPW with SVT, AF or Afi produce agina, syncope and hypotension RFCA
  • 62.
  • 63.
    Ventricular Premature Contractions(VPCs) Etiology: Occur in normal person Myocarditis, CAD, valve heart disease, hyperthyroidism, Drug toxicity (digoxin, quinidine and anti-anxiety drug) electrolyte disturbance, anxiety, drinking, coffee
  • 64.
    VPCs Manifestation: palpitation dizziness syncope loss of the second heart sound
  • 65.
    PVCs Therapy: treat underlying disease, antiarrhythmia No structure heart disease: Asymptom: no therapy Symptom caused by PVCs: antianxiety agents, ß -blocker and mexiletine to relief the symptom. With structure heart disease (CAD, HBP): Treat the underlying diseas ß -blocker, amiodarone Class I especially class Ic agents should be avoided because of proarrhytmia and lack of benefit of prophylaxis
  • 66.
    Ventricular tachycardia Etiology:often in organic heart disease CAD, MI, DCM, HCM, HF, long QT syndrome Brugada syndrome Sustained VT (>30s), Nonsustained VT Monomorphic VT, Polymorphic VT
  • 67.
    Ventricular tachycardia Torsadesde points (Tdp): A special type of polymorphic VT, Etiology: congenital (Long QT), electrolyte disturbance, antiarrhythmia drug proarrhythmia (IA or IC), antianxiety drug, brain disease, bradycardia
  • 68.
    Ventricular tachycardia Acceleratedidioventricular rhythm: Related to increase automatic tone Etiology : Often occur in organic heart disease, especially AMI reperfusion periods, heart operation, myocarditis, digitalis toxicity
  • 69.
    VT Manifestation: Nonsustained VT with no symptom Sustained VT : with symptom and unstable hemodynamic, patient may feel palpitation, short of breathness, presyncope, syncope, angina, hypotension and shock.
  • 70.
    VT ECG characteristics: Monomorphic VT: 100-250 bpm, occur and terminate abruptly,regular Accelerated idioventricular rhythm: a runs of 3-10 ventricular beats, rate of 60-110 bpm, tachycardia is a capable of warm up and close down, often seen AV dissociation, fusion or capture beats Tdp: rotation of the QRS axis around the baseline, the rate from 160-280 bpm, QT interval prolonged > 0.5s, marked U wave
  • 71.
    Treatment of VTTreat underlying disease Cardioversion: Hemodynamic unstable VT (hypotension, shock, angina, CHF) or hemodynamic stable but drug was no effect Pharmacological therapy: ß-blockers, lidocain or amiodarone RFCA, ICD or surgical therapy
  • 72.
    Therapy of Specialtype VT Accelerated idioventricular rhythm: usually no symptom, needn’t therapy. Atropine increased sinus rhythm Tdp: Treat underlying disease, Magnesium iv, atropine or isoprenaline, ß -block or pacemaker for long QT patient temporary pacemaker
  • 73.
    Ventricular flutter andfibrillation Often occur in severe organic heart disease: AMI, ischemia heart disease Proarrhythmia (especially produce long QT and Tdp), electrolyte disturbance Anaesthesia, lightning strike, electric shock, heart operation It’s a fatal arrhythmia
  • 74.
    Ventricular flutter andfibrillation Manifestation: Unconsciousness, twitch, no blood pressure and pulse, going to die Therapy: Cardio-Pulmonary Resuscitate (CPR) ICD
  • 75.
    Cardiac conduction blockBlock position: Sinoatrial; intra-atrial; atrioventricular; intra-ventricular Block degree Type I: prolong the conductive time Type II: partial block Type III: complete block
  • 76.
    Atrioventricular Block AVblock is a delay or failure in transmission of the cardiac impulse from atrium to ventricle. Etiology: Atherosclerotic heart disease; myocarditis; rheumatic fever; cardiomyopathy; drug toxicity; electrolyte disturbance, collagen disease, lev’s disease.
  • 77.
    AV Block AVblock is divided into three categories: First-degree AV block Second-degree AV block: further subdivided into type I and type II Third-degree AV block: complete block
  • 78.
    AV Block Manifestations:First-degree AV block: almost no symptoms; Second degree AV block: palpitation, fatigue Third degree AV block: Dizziness, agina, heart failure, lightheadedness, and syncope may cause by slow heart rate, Adams-Stokes Syndrome may occurs in sever case. First heart sound varies in intensity, will appear booming first sound
  • 79.
    AV Block Treatment:I or II degree AV block needn’t antibradycardia agent therapy II degree II type and III degree AV block need antibradycardia agent therapy Implant Pace Maker
  • 80.
    Intraventricular Block Intraventricularconduction system: Right bundle branch Left bundle branch Left anterior fascicular Left posterior fascicular
  • 81.
    Intraventricular Block Etiology:Myocarditis, valve disease, cardiomyopathy, CAD, hypertension, pulmonary heart disease, drug toxicity, Lenegre disease, Lev’s disease et al. Manifestation: Single fascicular or bifascicular block is asymptom; tri-fascicular block may have dizziness; palpitation, syncope and Adams-stokes syndrome
  • 82.
    Intraventricular Block Therapy:Treat underlying disease If the patient is asymptom; no treat, bifascicular block and incomplete trifascicular block may progress to complete block, may need implant pace maker if the patient with syncope